UFP Technologies, Inc. Operating Lease Cost
UFP Technologies, Inc. (UFPT) reported Operating Lease Cost of $2.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- UFP Technologies, Inc. operating lease, cost for the quarter ending 2026-06-30 was $1.47M, a 20.26% increase year-over-year.
- UFP Technologies, Inc. operating lease, cost for the quarter ending 2026-03-31 was $1.41M, a 28.53% increase year-over-year.
- UFP Technologies, Inc. operating lease, cost for the quarter ending 2025-12-31 was $1.30M, a 21.12% increase year-over-year.
- UFP Technologies, Inc. operating lease, cost for the quarter ending 2025-09-30 was $1.37M, a 28.88% increase year-over-year.
- UFP Technologies, Inc. operating lease, cost for fiscal 2025 was $4.99M, a 29.65% increase from fiscal 2024.
- UFP Technologies, Inc. operating lease, cost for fiscal 2024 was $3.85M, a 22.96% increase from fiscal 2023.
- UFP Technologies, Inc. operating lease, cost for fiscal 2023 was $3.13M, a 19.50% increase from fiscal 2022.
- UFP Technologies, Inc. operating lease, cost for fiscal 2022 was $2.62M, a 107.52% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.88M 10-Q · filed 2026-08-06 | $4.18M derived: sum of 3 quarters · filed 2026-08-06 | $5.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.41M 10-Q · filed 2026-05-08 | $2.71M derived: sum of 2 quarters · filed 2026-05-08 | $4.08M derived: sum of 3 quarters · filed 2026-05-08 | $5.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.67M derived: sum of 2 quarters · filed 2026-02-27 | $3.90M derived: sum of 3 quarters · filed 2026-08-06 | $4.99M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.59M derived: sum of 2 quarters · filed 2026-08-06 | $3.69M 10-Q · filed 2025-11-07 | $4.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.32M 10-Q · filed 2026-08-06 | $3.40M derived: sum of 3 quarters · filed 2026-08-06 | $4.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.10M 10-Q · filed 2026-05-08 | $2.17M derived: sum of 2 quarters · filed 2026-05-08 | $3.23M derived: sum of 3 quarters · filed 2026-05-08 | $4.09M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.14M derived: sum of 2 quarters · filed 2026-02-27 | $3.00M derived: sum of 3 quarters · filed 2026-02-27 | $3.85M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.92M derived: sum of 2 quarters · filed 2025-11-07 | $2.78M 10-Q · filed 2025-11-07 | $3.60M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $858.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.71M 10-Q · filed 2025-08-11 | $2.54M derived: sum of 3 quarters · filed 2026-02-27 | $3.37M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $855.00K 10-Q · filed 2025-05-12 | $1.68M derived: sum of 2 quarters · filed 2026-02-27 | $2.51M derived: sum of 3 quarters · filed 2026-02-27 | $3.28M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $828.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.65M derived: sum of 2 quarters · filed 2026-02-27 | $2.42M derived: sum of 3 quarters · filed 2026-02-27 | $3.13M 10-K · filed 2026-02-27 |
| 2023-09-30 | $824.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.59M derived: sum of 2 quarters · filed 2024-11-12 | $2.30M 10-Q · filed 2024-11-12 | $2.96M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.48M 10-Q · filed 2024-08-09 | $2.14M derived: sum of 3 quarters · filed 2024-08-09 | $2.80M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $711.00K 10-Q · filed 2024-05-10 | $1.37M derived: sum of 2 quarters · filed 2024-05-10 | $2.03M derived: sum of 3 quarters · filed 2024-05-10 | $2.68M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.32M derived: sum of 2 quarters · filed 2024-02-29 | $1.97M derived: sum of 3 quarters · filed 2024-02-29 | $2.62M 10-K · filed 2024-02-29 |
| 2022-09-30 | $661.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.31M derived: sum of 2 quarters · filed 2023-11-09 | $1.96M 10-Q · filed 2023-11-09 | $2.33M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $649.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.30M 10-Q · filed 2023-08-09 | $1.67M derived: sum of 3 quarters · filed 2023-08-09 | $1.97M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $652.00K 10-Q · filed 2023-05-10 | $1.02M derived: sum of 2 quarters · filed 2023-05-10 | $1.32M derived: sum of 3 quarters · filed 2023-05-10 | $1.61M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $367.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-16 | $665.00K derived: sum of 2 quarters · filed 2023-03-16 | $963.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.26M 10-K · filed 2023-03-16 |
| 2021-09-30 | $298.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14 | $596.00K derived: sum of 2 quarters · filed 2022-11-14 | $896.00K 10-Q/A · filed 2022-11-14 | $1.20M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $598.00K 10-Q · filed 2022-08-09 | $898.00K derived: sum of 3 quarters · filed 2022-08-09 | $1.20M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-10 | $600.00K derived: sum of 2 quarters · filed 2022-05-10 | $901.00K derived: sum of 3 quarters · filed 2022-05-10 | $1.20M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $601.00K derived: sum of 2 quarters · filed 2022-03-14 | $902.00K derived: sum of 3 quarters · filed 2022-03-14 | $1.21M 10-K · filed 2022-03-14 |
| 2020-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $602.00K derived: sum of 2 quarters · filed 2021-11-05 | $907.00K 10-Q · filed 2021-11-05 | $1.21M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $606.00K 10-Q · filed 2021-08-06 | $910.00K derived: sum of 3 quarters · filed 2021-08-06 | $1.22M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $305.00K 10-Q · filed 2021-05-07 | $609.00K derived: sum of 2 quarters · filed 2021-05-07 | $914.00K derived: sum of 3 quarters · filed 2021-05-07 | $1.22M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $609.00K derived: sum of 2 quarters · filed 2021-03-12 | $915.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.22M 10-K · filed 2021-03-12 |
| 2019-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $611.00K derived: sum of 2 quarters · filed 2020-11-06 | $918.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $306.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $613.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $307.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |